NEW YORK (GenomeWeb News) – Chromatide and Novasep have agreed to extend a research partnership focused on developing peptide and oligonucleotide synthesis technology, Novasep said Friday.
Novasep said the companies plan to combine its synthesis and purification services, which pharmaceutical companies use to produce pure peptides and oligonucleotides, with Chromatide’s experience in peptide and oligonucleotide synthesis, including production of novel resins and instruments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.